Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines – MedCity News

The companies anticipate releasing more clinical data from the BNT162 messenger RNA vaccine program and potentially starting a 30,000-participant Phase IIb/III study this month.

Read the full article here

Related Articles